Drug intelligence / Profile preview

Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester

Development stage
Unknown
Modality
Peptides, Small Molecules
01

Overview

Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester is a synthetic small molecule belonging to the class of serine protease inhibitors. It is structurally characterized as a peptide derivative and has been studied primarily as an experimental compound, not approved for clinical use. The compound acts by binding to the active site of serine proteases such as trypsin and thrombin, inhibiting their enzymatic activity. Structural studies have shown that it fits into the specificity pocket of these enzymes, with its amidinophenylalanine moiety engaging key residues in the active site[1][4][5]. Its primary research application has been in structural biology and enzymology for understanding protease-inhibitor interactions.

Other names
methyl (2S)-3-(3-carbamimidoylphenyl)-2-[2-(4-methylbenzenesulfonamido)acetamido]propanoateCAS 133397-81-6CAS133397-81-6CAS-133397-81-6DB01737DB-01737DB 01737
02

Targets

F2 (Thrombin)PRSS1 (Trypsin family)

Beyond the preview

Go deeper on Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call